The Cell and Gene Therapy Manufacturing Services Market in 2023 is US$ 6 billion, and is expected to reach US$ 22.14 billion by 2031 at a CAGR of 17.70%.
FutureWise Research published a report that analyzes Cell and Gene Therapy Manufacturing Services Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Cell and Gene Therapy Manufacturing Services research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.
Request a Sample Report @ Request for Cell and Gene Therapy Manufacturing Services Market Sample
Cell and Gene Therapy Manufacturing Services Market Segmentation:
By Type
· Cell Therapy
· Allogeneic
· Mesenchymal Stem Cells
· T-cells
· Induced Pluripotent Stem Cells
· Natural Killer Cells
· Hematopoietic Stem Cells
· Other Allogeneic Cells
· Autologous
· T-cells
· Hematopoietic Stem Cells
· Mesenchymal Stem Cells
· Natural Killer Cells
· Viral Vector
· Retroviral Vectors
· Adeno-associated Virus Vectors
· Other Viral Vectors
· Gene Therapy
· Non-viral Vector
· Oligonucleotides
· Other Non-viral Vectors
· Viral Vector
· Retroviral Vectors
· Adeno-associated Virus Vectors
· Other Viral Vectors
By Indication
· Oncology Diseases
· Cardiovascular Diseases
· Orthopedic Diseases
· Ophthalmology Diseases
· Central Nervous System Disorders
· Infectious Diseases
· Other Indications
By Application
· Clinical Manufacturing
· Commercial Manufacturing
By End User
· Pharmaceutical and Biotechnology Companies
· Academic and Research Institutes
· Other End Users
By Region
· North America
· Europe
· Asia-Pacific
· Latin America
· Middle East and Africa
Major players included in the Cell and Gene Therapy Manufacturing Services Market:
· Thermo Fisher Scientific, Inc.
· Merck KGaA
· Charles River Laboratories
· Lonza
· Catalent, Inc.
· WuXi AppTec
· Takara Bio Inc
· Nikon Corporation
· Fujifilm Holdings Corporation
· F. Hoffmann-La Roche Ltd.
· Oxford Biomedica plc
· Cell and Gene Therapy Catapult
· The Discovery Labs LLC
· RoslinCT
· Jrs Pharma
· FinVector
· ABL, Inc.
· Resilience
· BioCentriq
